Are you Dr. Lo?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 48 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
200 UCLA Medical Plz Ste 450
Los Angeles, CA 90095Phone+1 310-825-6911Fax+1 310-794-7005
Summary
- Dr. Roger Lo, MD is a dermatologist in Los Angeles, California. He is currently licensed to practice medicine in California. He is an Assistant Professor of Dermatology at UCLA.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Dermatology, 2003 - 2007
Westchester Medical CenterInternship, Internal Medicine, 2002 - 2003
Weill Cornell MedicineClass of 2002
Certifications & Licensure
CA State Medical License 2003 - 2025- National Board of Physicians and Surgeons Dermatology
Awards, Honors, & Recognition
- Top Doctors:LA Area Castle Connolly, 2013
- Top Doctors:Southern California Castle Connolly, 2012
- Elected Member The American Society for Clinical Investigation, 2012
Publications & Presentations
PubMed
- 69 citationsAnti-PD-1/L1 lead-in before MAPK inhibitor combination maximizes antitumor immunity and efficacy.Yujue Wang, Sixue Liu, Zhentao Yang, Alain Algazi, Shirley H. Lomeli
Cancer Cell. 2021-10-11 - 275 citationssFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistanceAmanpreet Kaur, Marie R. Webster, Katie Marchbank, Reeti Behera, Abibatou Ndoye
Nature. 2016-04-14 - 91 citationsAntitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanomaDeborah J.L. Wong, Lidia Robert, Mohammad Atefi, Amanda Lassen, Geetha Avarappatt
Molecular Cancer. 2014-08-20
Press Mentions
Dr. Roger Lo Awarded NIH Grant to Tackle Melanoma Treatment ResistanceSeptember 24th, 2024- “Rapid Autopsies” Offer New Perspective of Melanoma ProgressionMay 3rd, 2023
- Researchers Study Genetic Changes in Tumors of Recently Deceased Patients with MelanomaMay 2nd, 2023
- Join now to see all
Grant Support
- Augmenting Melanoma Response To B-RAF V600E TargetingNational Cancer Institute2010–2011
Other Languages
- Chinese (Mandarin)
